Inogen (INGN) Net Income towards Common Stockholders Growth (3y) (2016 - 2026)
Powered by 
Analysis
Inogen (INGN) Net Income towards Common Stockholders Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 22.97% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 51.47% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -7.83% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 29.05% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 17.54% |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 27.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.88% |
| Mar 31, 2026 | 25.88% |
| Dec 31, 2025 | 60.81% |
| Sep 30, 2025 | 14.48% |
| Jun 30, 2025 | -18.82% |
| Mar 31, 2025 | 22.90% |
| Dec 31, 2024 | 24.38% |
| Sep 30, 2024 | -35.46% |
| Jun 30, 2024 | -46.20% |
| Mar 31, 2024 | -146.53% |
| Dec 31, 2023 | -73.63% |
| Sep 30, 2023 | -199.64% |
| Jun 30, 2023 | -79.76% |
| Mar 31, 2023 | -133.96% |
| Dec 31, 2022 | -246.05% |
| Sep 30, 2022 | -50.15% |
| Jun 30, 2022 | -31.60% |
| Mar 31, 2022 | -66.25% |
| Dec 31, 2021 | -61.93% |
| Sep 30, 2021 | -9.25% |